News Relmada Therapeutics Acquires Sepranolone from Asarina Pharma for ~$3.12MByRidhi RastogiFebruary 7, 20250Comments
News Merck Initiates P-III (waveLINE-010) Trial of Zilovertamab Vedotin to Treat Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL)ByRidhi RastogiFebruary 7, 20250Comments
News The US FDA Approves Supernus’ Onapgo (Apomorphine Hydrochloride) for Parkinson’s DiseaseByRidhi RastogiFebruary 7, 20250Comments
News Adicet Bio’s ADI-001 Secures the US FDA’s Fast-Track Designation for Treating Refractory SLE with Extrarenal InvolvementByRidhi RastogiFebruary 6, 20250Comments
THOUGHTSPOT How Pharma and Social Work Can Collaborate on Chronic Disease ManagementByCarla AdamsFebruary 6, 20250Comments
News AstraZeneca Reports CHMP Positive Opinion for Imfinzi to Treat Limited-Stage Small Cell Lung Cancer (LS-SCLC)ByRidhi RastogiFebruary 6, 20250Comments
News Accord Healthcare (Intas) Receives EC Approval for Hetronifly (Serplulimab) as 1L Treatment of ES-SCLCByRidhi RastogiFebruary 6, 20250Comments
News The US FDA grants RMAT Designation to Gradalis’ Vigil for Advanced Ovarian CancerByRidhi RastogiFebruary 6, 20250Comments
